Evaluation of Completeness of Suspected Adverse Drug Reaction Reports Submitted to the Mexican National Pharmacovigilance CentreA Cross-Sectional Period-Prevalence Study

被引：0
|
作者：
Betsabé Sánchez-Sánchez
Marina Altagracia-Martínez
Jaime Kravzov-Jinich
Consuelo Moreno-Bonett
Everardo Vázquez-Moreno
Juan Manuel Martínez-Núñez
机构：
[1] Metropolitan Autonomous University-Xochimilco,Division of Biological and Health Sciences, Department of Biological Systems
[2] Pfizer Laboratory,undefined
来源：
Drug Safety | 2012年 / 35卷
关键词：
Adverse Drug Reaction; Pharmaceutical Industry; Pregabalin; Adverse Drug Reaction Report; Anatomical Therapeutic Chemical Classification;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: The Mexican National Centre of Pharmacovigilance (CNFV) receives suspected adverse drug reaction (ADR) reports from the pharmaceutical industry, Federal States Centre of Pharmacovigilance (CEFV) and Healthcare Institution Centres of Pharmacovigilance (CIFV). The completeness of these suspected ADR reports is particularly important for the proper evaluation of drug safety.
引用
收藏
页码：837 / 844
页数：7
相关论文
共 50 条
  • [1] Evaluation of Completeness of Suspected Adverse Drug Reaction Reports Submitted to the Mexican National Pharmacovigilance Centre A Cross-Sectional Period-Prevalence Study
    Sanchez-Sanchez, Betsabe
    Altagracia-Martinez, Marina
    Kravzov-Jinich, Jaime
    Moreno-Bonett, Consuelo
    Vazquez-Moreno, Everardo
    Manuel Martinez-Nunez, Juan
    DRUG SAFETY, 2012, 35 (10) : 837 - 844
  • [2] Suspected adverse drug reaction reports with oral anticoagulants in Portugal: a pharmacovigilance study
    Caldeira, Daniel
    Rodrigues, Raquel
    Abreu, Daisy
    Anes, Ana Marta
    Rosa, Mario M.
    Ferreira, Joaquim J.
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (04) : 339 - 345
  • [3] Pharmacovigilance and Adverse Drug Reaction Reporting among the General Public in Lithuania: A Cross-Sectional Study
    Valinciute, Agne
    Gerbutaviciene, Rima Jurate
    Paukstaitiene, Renata
    Kubiliene, Loreta
    HEALTHCARE, 2023, 11 (08)
  • [4] Quantity is not enough: completeness of suspected adverse drug reaction reports in Spain—differences between regional pharmacovigilance centres and pharmaceutical industry
    C. Fernandez-Fernandez
    E. Lázaro-Bengoa
    E. Fernández-Antón
    L. Quiroga-González
    D. Montero Corominas
    European Journal of Clinical Pharmacology, 2020, 76 : 1175 - 1181
  • [5] Nursing Professionals' Awareness of Adverse Drug Reactions and Pharmacovigilance in an Institute of National Importance in India: A Cross-Sectional Study
    Bankar, Mangesh
    Tewari, Sachchidanand
    Kumar, Subodh
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [6] Evaluation of health care professionals' knowledge, attitudes, practices and barriers to pharmacovigilance and adverse drug reaction reporting: A cross-sectional multicentral study
    Khan, Zakir
    Karatas, Yusuf
    Hamid, Syed Muhammad
    PLOS ONE, 2023, 18 (05):
  • [7] Completeness of Spontaneous Adverse Drug Reaction Reports Sent by General Practitioners to a Regional Pharmacovigilance Centre: A Descriptive Study
    Durrieu, Genevieve
    Jacquot, Julien
    Mege, Mathilde
    Bondon-Guitton, Emmanuelle
    Rousseau, Vanessa
    Montastruc, Francois
    Montastruc, Jean-Louis
    DRUG SAFETY, 2016, 39 (12) : 1189 - 1195
  • [8] Suspected adverse drug reactions reported for Brazilian children: cross-sectional study
    Lima, Elisangela da Costa
    de Matos, Guacira Correa
    Vieira, Jean M. de L.
    Goncalves, Ivana C. da C. R.
    Cabral, Lucio M.
    Turner, Mark A.
    JORNAL DE PEDIATRIA, 2019, 95 (06) : 682 - 688
  • [9] An investigation of pharmacovigilance and reporting of adverse drug reactions in hospitals: a cross-sectional study in China
    Zhao, Zhigang
    Shen, Jiashu
    Shen, Chuanyong
    Zhu, Bin
    Sun, Jun
    Yu, Jinyang
    Sun, Feng
    Song, Haibo
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (11) : 2001 - 2006
  • [10] Completeness of Spontaneous Adverse Drug Reaction Reports Sent by General Practitioners to a Regional Pharmacovigilance Centre: A Descriptive Study
    Geneviève Durrieu
    Julien Jacquot
    Mathilde Mège
    Emmanuelle Bondon-Guitton
    Vanessa Rousseau
    François Montastruc
    Jean-Louis Montastruc
    Drug Safety, 2016, 39 : 1189 - 1195
12345